1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Orthopedics Market Trends
  5. > United States Orthobiologics Market Outlook to 2021

United States Orthobiologics Market Outlook to 2021

  • September 2015
  • -
  • Global Data
  • -
  • 86 pages

United States Orthobiologics Market Outlook to 2021

Summary

GlobalData’s new report, "United States Orthobiologics Market Outlook to 2021", provides key market data on the United States Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market segments - Bone Graft and Substitutes, Viscosupplementation and Bone Growth Stimulators.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Orthobiologics market categories - Bone Graft and Substitutes, Viscosupplementation and Bone Growth Stimulators.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Orthobiologics market.
- Global corporate-level profiles of key companies operating within the United States Orthobiologics market.
- Key players covered include DePuy Companies, Sanofi, Medtronic, Inc., NuVasive, Inc., Biomet, Inc., Smith & Nephew Plc, Baxter International Inc., Wright Medical Group, Inc. and Stryker Corporation.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

United States Orthobiologics Market Outlook to 2021
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About? 6
2.2 Orthobiologics Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 7
3 Orthobiologics Market, United States 9
3.1 Orthobiologics Market, United States, Revenue ($m), 2007-2014 9
3.2 Orthobiologics Market, United States, Revenue ($m), 2014-2021 11
3.2.1 Bone Grafts and Substitutes Market, United States, Revenue ($m), by Segment, 2007-2014 13
3.2.2 Bone Growth Stimulators Market, United States, Revenue ($m), by Segment, 2007-2014 15
3.2.3 Viscosupplementation Market, United States, Revenue ($m), by Segment, 2007-2014 17
3.2.4 Bone Grafts and Substitutes Market, United States, Revenue ($m), by Segment, 2014-2021 19
3.2.5 Bone Growth Stimulators Market, United States, Revenue ($m), by Segment, 2014-2021 21
3.2.6 Viscosupplementation Market, United States, Revenue ($m), by Segment, 2014-2021 23
3.3 Orthobiologics Market, United States, Volume (Units), 2007-2014 25
3.4 Orthobiologics Market, United States, Volume (Units), 2014-2021 27
3.4.1 Bone Grafts and Substitutes Market, United States, Volume (Units), by Segment, 2007-2014 29
3.4.2 Bone Growth Stimulators Market, United States, Volume (Units), by Segment, 2007-2014 31
3.4.3 Viscosupplementation Market, United States, Volume (Units), by Segment, 2007-2014 33
3.4.4 Bone Grafts and Substitutes Market, United States, Volume (Units), by Segment, 2014-2021 35
3.4.5 Bone Growth Stimulators Market, United States, Volume (Units), by Segment, 2014-2021 37
3.4.6 Viscosupplementation Market, United States, Volume (Units), by Segment, 2014-2021 39
3.5 Orthobiologics Market, United States, Average Price ($), 2007-2021 41
3.6 Orthobiologics Market, United States, Distribution Share by Revenue ($m), 2013-2014 43
3.7 Orthobiologics Market, United States, Company Share by Revenue ($m), 2014 44
4 Overview of Key Companies in United States, Orthobiologics Market 46
4.1 DePuy Companies 46
4.1.1 Company Overview 46
4.2 Sanofi 46
4.2.1 Company Overview 46
4.3 Medtronic plc 46
4.3.1 Company Overview 46
4.4 Ferring International Center S.A. 47
4.4.1 Company Overview 47
4.5 Bioventus LLC 47
4.5.1 Company Overview 47
4.6 DJO Finance LLC 47
4.6.1 Company Overview 47
4.7 Stryker Corporation 47
4.7.1 Company Overview 47
4.8 Seikagaku Corporation 48
4.8.1 Company Overview 48
4.9 Arthrex, Inc. 48
4.9.1 Company Overview 48
4.10 Biomet, Inc. (Inactive) 48
4.10.1 Company Overview 48
4.11 Wright Medical Group, Inc. 49
4.11.1 Company Overview 49
4.12 Baxter International Inc. 49
4.12.1 Company Overview 49
5 Orthobiologics Market Pipeline Products 50
6 Financial Deals Landscape 54
6.1 Debt Offerings 54
6.1.1 Medtronic Raises USD500 Million in Private Placement of Notes Due 2020 54
6.1.2 Medtronic Raises USD2.5 Billion in Private Placement of 2.5% Notes Due 2020 56
6.1.3 Medtronic Raises USD2.5 Billion in Private Placement of 3.15% Notes Due 2022 58
6.1.4 Medtronic Raises USD4 Billion in Private Placement of 3.5% Notes Due 2025 60
6.1.5 Medtronic Raises USD2.5 Billion in Private Placement of 4.375% Notes Due 2035 62
6.1.6 Medtronic Raises USD4 Billion in Private Placement of 4.625% Notes Due 2045 64
6.1.7 Medtronic Raises USD1 Billion in Private Placement of Notes Due 2018 66
6.2 Equity Offerings 68
6.2.1 Integra LifeSciences Prices Public Offering of Shares for USD201.3 Million 68
6.2.2 Histogenics Prices IPO for USD65 Million 70
6.3 Merger 72
6.3.1 Wright Medical to Merge with Tornier 72
6.3.2 AFH Acquisition Merges with Bone Biologics in Reverse Merger Transaction 74
6.4 Partnerships 75
6.4.1 CollPlant to Enter into Agreement with US based company 75
6.4.2 Osiris Therapeutics Enters into Co-Development Agreement with Arthrex for Cartiform 76
6.5 Venture Financing 77
6.5.1 Tissue Regeneration Raises USD0.5 Million in Venture Financing 77
7 Appendix 78
7.1 Research Methodology 79
7.1.1 Coverage 79
7.1.2 Secondary Research 79
7.1.3 Primary Research 80
7.1.4 Market Modeling and Forecasting 81
7.1.5 Company Share Analysis 84
7.1.6 Distribution Share Analysis 85
7.2 Expert Panel 86
7.3 GlobalData Consulting 86
7.4 Contact Us 86
7.5 Disclaimer 86

1.1 List of Tables
Table 1: Orthobiologics Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 10
Table 2: Orthobiologics Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 12
Table 3: Bone Grafts and Substitutes Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 14
Table 4: Bone Growth Stimulators Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 16
Table 5: Viscosupplementation Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 18
Table 6: Bone Grafts and Substitutes Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 20
Table 7: Bone Growth Stimulators Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 22
Table 8: Viscosupplementation Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 24
Table 9: Orthobiologics Market, United States, Volume (Units), Historic, 2007-2014 26
Table 10: Orthobiologics Market, United States, Volume (Units), Forecast, 2014-2021 28
Table 11: Bone Grafts and Substitutes Market, United States, Volume (Units), Historic, 2007-2014 30
Table 12: Bone Growth Stimulators Market, United States, Volume (Units), Historic, 2007-2014 32
Table 13: Viscosupplementation Market, United States, Volume (Units), Historic, 2007-2014 34
Table 14: Bone Grafts and Substitutes Market, United States, Volume (Units), Forecast, 2014-2021 36
Table 15: Bone Growth Stimulators Market, United States, Volume (Units), Forecast, 2014-2021 38
Table 16: Viscosupplementation Market, United States, Volume (Units), Forecast, 2014-2021 40
Table 17: Orthobiologics Market, United States, Average Price ($) Historic, 2007-2014 41
Table 18: Orthobiologics Market, United States, Average Price ($), Forecast, 2014-2021 42
Table 19: Orthobiologics Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014 43
Table 20: Orthobiologics Market, United States, Company Share by Revenue ($m), USD Constant, 2014 45
Table 21: Orthobiologics Market Pipeline Products 50
Table 22: Medtronic Raises USD500 Million in Private Placement of Notes Due 2020 54
Table 23: Medtronic Raises USD2.5 Billion in Private Placement of 2.5% Notes Due 2020 56
Table 24: Medtronic Raises USD2.5 Billion in Private Placement of 3.15% Notes Due 2022 58
Table 25: Medtronic Raises USD4 Billion in Private Placement of 3.5% Notes Due 2025 60
Table 26: Medtronic Raises USD2.5 Billion in Private Placement of 4.375% Notes Due 2035 62
Table 27: Medtronic Raises USD4 Billion in Private Placement of 4.625% Notes Due 2045 64
Table 28: Medtronic Raises USD1 Billion in Private Placement of Notes Due 2018 66
Table 29: Integra LifeSciences Prices Public Offering of Shares for USD201.3 Million 68
Table 30: Histogenics Prices IPO for USD65 Million 70
Table 31: Wright Medical to Merge with Tornier 72
Table 32: AFH Acquisition Merges with Bone Biologics in Reverse Merger Transaction 74
Table 33: CollPlant to Enter into Agreement with US based company 75
Table 34: Osiris Therapeutics Enters into Co-Development Agreement with Arthrex for Cartiform 76
Table 35: Tissue Regeneration Raises USD0.5 Million in Venture Financing 77
Table 36: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 81

1.2 List of Figures
Figure 1: Orthobiologics Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 9
Figure 2: Orthobiologics Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 11
Figure 3: Bone Grafts and Substitutes Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 13
Figure 4: Bone Growth Stimulators Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 15
Figure 5: Viscosupplementation Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 17
Figure 6: Bone Grafts and Substitutes Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 19
Figure 7: Bone Growth Stimulators Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 21
Figure 8: Viscosupplementation Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 23
Figure 9: Orthobiologics Market, United States, Volume (Units), Historic, 2007-2014 25
Figure 10: Orthobiologics Market, United States, Volume (Units), Forecast, 2014-2021 27
Figure 11: Bone Grafts and Substitutes Market, United States, Volume (Units), Historic, 2007-2014 29
Figure 12: Bone Growth Stimulators Market, United States, Volume (Units), Historic, 2007-2014 31
Figure 13: Viscosupplementation Market, United States, Volume (Units), Historic, 2007-2014 33
Figure 14: Bone Grafts and Substitutes Market, United States, Volume (Units), Forecast, 2014-2021 35
Figure 15: Bone Growth Stimulators Market, United States, Volume (Units), Forecast, 2014-2021 37
Figure 16: Viscosupplementation Market, United States, Volume (Units), Forecast, 2014-2021 39
Figure 17: Orthobiologics Market, United States, Company Share (%) 2014 44
Figure 18: GlobalData Epidemiology-Based Forecasting Model 83
Figure 19: GlobalData Capital Equipment-Based Forecasting Model 84
Figure 20: Primary Interviews by Participant Type (%) 85

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Norway Orthopedic Devices Market Outlook to 2022 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Norway Orthopedic Devices Market Outlook to 2022 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

  • $ 5995
  • Industry report
  • September 2016
  • by Global Data

Norway Orthopedic Devices Market Outlook to 2022 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others ...

Turkey Orthopedic Devices Market Outlook to 2022 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Turkey Orthopedic Devices Market Outlook to 2022 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

  • $ 5995
  • Industry report
  • September 2016
  • by Global Data

Turkey Orthopedic Devices Market Outlook to 2022 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others ...

Israel Orthopedic Devices Market Outlook to 2022 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Israel Orthopedic Devices Market Outlook to 2022 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

  • $ 5995
  • Industry report
  • September 2016
  • by Global Data

Israel Orthopedic Devices Market Outlook to 2022 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others ...


Download Unlimited Documents from Trusted Public Sources

Orthobiologics Markets in Europe - Forecast

  • June 2016
    44 pages
  • Orthobiologics  

  • Europe  

View report >

Global Orthopedics Industry

  • January 2016
    22 pages
  • Orthopedics  

  • France  

    Europe  

    World  

View report >

Spinal Device Industry in France and the US

  • October 2016
    2 pages
  • Spinal Device  

    Orthopedics  

  • France  

    United States  

View report >

Related Market Segments :

Orthobiologics
Therapy

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.